Comparative Study (Double-Blind) of MRA for Rheumatoid Arthritis (RA)
Status:
Completed
Trial end date:
2006-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the clinical efficacy and safety of MRA in a
double-blind, parallel-group, controlled study using MRA or methotrexate (MTX) in rheumatoid
arthritis (RA) patients with MTX administered.